CAGRILINTIDE

Chain: 31–amino acid analog of the naturally occurring amylin hormone.
Research focus: Explored for appetite regulation, delayed gastric emptying, and synergy with GLP agonists in metabolic research.
Studies: Clinical trials (e.g., JAMA 2021) show reduced food intake and significant body-weight loss when combined with semaglutide or tirzepatide analogs.
Highlights: Investigated for its potential in satiety signaling and metabolic rate modulation.
Disclaimer: Intended for research purposes only. Not for human or animal consumption.